Table II. Toxicities Grade 3 or Higher Observed in > 10% of Patients during Induction cycles I and II.
Adverse Event ≥ Grade 3 | Induction, Cycle I (N=49) | Induction, Cycle II (N=31) | ||
---|---|---|---|---|
N | % | N | % | |
Febrile neutropenia | 20 | 41% | 9 | 29% |
Infections and infestations | 23 | 47% | 13 | 42% |
Hypokalemia | 10 | 20% | 10 | 32% |
Anorexia | 7 | 14% | 2 | 6% |
Diarrhea | 6 | 12% | 3 | 10% |
Nausea | 6 | 12% | 2 | 6% |
Hyperglycemia | 6 | 12% | 2 | 6% |
Alanine aminotransferase increased | 6 | 12% | 6 | 19% |
Aspartate aminotransferase increased | 4 | 8% | 3 | 10% |